Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2978.4%
Neutral718.9%
Bearish12.7%
FN2 Earnings Intelligence
Ecolab Inc. analyst ratings
Ecolab Inc. (ECL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$283.07Current
$164Low
$279.13Average
$426High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Perform | Upgrade | Jul 17, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jun 10, 2026 |
| UBS | Buy | Neutral | Upgrade | May 27, 2026 |
| Jefferies | Buy | Buy | Maintain | May 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 21, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Mar 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Mar 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 18, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 13, 2026 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Feb 12, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Feb 12, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 29, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Jul 15, 2025 |
| Seaport Global | Buy | Neutral | Upgrade | Apr 21, 2025 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Mar 24, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 24, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jan 28, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Apr 3, 2024 |
| Northcoast Research | Neutral | Buy | Downgrade | Jul 5, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 7, 2022 |
| Argus Research | Buy | Buy | Maintain | May 31, 2022 |
| Edward Jones | Buy | Hold | Upgrade | Mar 17, 2022 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jan 15, 2021 |
| CFRA | Hold | Hold | Maintain | Apr 30, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 19, 2020 |
| Nomura | Buy | Buy | Maintain | Aug 7, 2019 |
| Citi | Neutral | Neutral | Maintain | Aug 2, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | May 1, 2019 |
| Longbow Research | Neutral | Buy | Downgrade | Feb 22, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Aug 25, 2016 |
| Goldman Sachs | Sell | Sell | Maintain | Aug 3, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Mar 22, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 3, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $283.07. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Scott Schneeberger | $320 | $275.71 | +13.0% | Jul 17, 2026 |
| Deutsche Bank | Analyst unavailable | $335 | $272.13 | +18.3% | Jul 9, 2026 |
| Wells Fargo | Jason Hass | $275 | $264.44 | -2.9% | Jun 10, 2026 |
| UBS | Joshua Spector | $325 | $254.23 | +14.8% | May 27, 2026 |
| Jefferies | Analyst unavailable | $345 | $250.22 | +21.9% | May 20, 2026 |
| UBS | Analyst unavailable | $293 | $272.47 | +3.5% | Apr 9, 2026 |
| Evercore ISI | Analyst unavailable | $312 | $305 | +10.2% | Feb 18, 2026 |
| Deutsche Bank | David Begleiter | $325 | $300.28 | +14.8% | Feb 13, 2026 |
| BMO Capital | John McNulty | $345 | $300.69 | +21.9% | Feb 13, 2026 |
| Seaport Global | Analyst unavailable | $340 | $304.59 | +20.1% | Feb 12, 2026 |
| UBS | Analyst unavailable | $312 | $300.56 | +10.2% | Feb 11, 2026 |
| Morgan Stanley | Analyst unavailable | $330 | $300.64 | +16.6% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $335 | $299.62 | +18.3% | Feb 11, 2026 |
| Robert W. Baird | Andrew Wittmann | $327 | $299.62 | +15.5% | Feb 11, 2026 |
| Stifel Nicolaus | Analyst unavailable | $337 | $299.62 | +19.1% | Feb 11, 2026 |
| UBS | Analyst unavailable | $295 | $270.96 | +4.2% | Jan 7, 2026 |
| Evercore ISI | Eric Boyes | $300 | $256.4 | +6.0% | Nov 3, 2025 |
| UBS | Analyst unavailable | $291 | $256.18 | +2.8% | Oct 31, 2025 |
| BMO Capital | John McNulty | $307 | $260.56 | +8.5% | Oct 30, 2025 |
| Mizuho Securities | John Roberts | $315 | $268.28 | +11.3% | Oct 29, 2025 |
| Stifel Nicolaus | Analyst unavailable | $300 | $265.41 | +6.0% | Oct 29, 2025 |
| Robert W. Baird | Analyst unavailable | $307 | $268.28 | +8.5% | Oct 29, 2025 |
| Barclays | Manav Patnaik | $300 | $268.28 | +6.0% | Oct 29, 2025 |
| UBS | Joshua Spector | $299 | $278.91 | +5.6% | Oct 6, 2025 |
| BMO Capital | John McNulty | $310 | $275.35 | +9.5% | Sep 8, 2025 |
| Jefferies | Andrew Andersen | $426 | $265.09 | +50.5% | Jul 30, 2025 |
| Wells Fargo | Jason Haas | $260 | $262.38 | -8.1% | May 20, 2025 |
| Robert W. Baird | Andrew Wittmann | $277 | $253.66 | -2.1% | Apr 2, 2025 |
| UBS | Joshua Spector | $276 | $244.5 | -2.5% | Nov 4, 2024 |
| BMO Capital | John McNulty | $279 | $254.46 | -1.4% | Oct 30, 2024 |
| Citigroup | Pat Cunningham | $292 | $253.76 | +3.2% | Oct 29, 2024 |
| Morgan Stanley | Vincent Andrews | $240 | $254.26 | -15.2% | Oct 29, 2024 |
| Jefferies | Laurence Alexander | $310 | $257.1 | +9.5% | Oct 18, 2024 |
| Wells Fargo | Jason Haas | $295 | $251.02 | +4.2% | Oct 7, 2024 |
| Piper Sandler | Charles Neivert | $305 | $254.82 | +7.7% | Sep 26, 2024 |
| RBC Capital | Ashish Sabadra | $306 | $250.54 | +8.1% | Sep 16, 2024 |
| Mizuho Securities | John Roberts | $291 | $250.87 | +2.8% | Sep 3, 2024 |
| Wells Fargo | Jason Haas | $270 | $237.24 | -4.6% | Aug 12, 2024 |
| Bank of America Securities | Steve Byrne | $272 | $228.86 | -3.9% | Jul 31, 2024 |
| Deutsche Bank | David Begleiter | $245 | $228.86 | -13.4% | Jul 31, 2024 |
| Citigroup | Pat Cunningham | $265 | $228.86 | -6.4% | Jul 31, 2024 |
| UBS | Joshua Spector | $282 | $242.84 | -0.4% | Jul 9, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $283 | $238.19 | -0.0% | Jul 8, 2024 |
| RBC Capital | Ashish Sabadra | $260 | $234.69 | -8.1% | May 21, 2024 |
| UBS | Joshua Spector | $270 | $234.69 | -4.6% | May 21, 2024 |
| BMO Capital | John McNulty | $234 | $224.84 | -17.3% | May 1, 2024 |
| Mizuho Securities | John Roberts | $260 | $220.75 | -8.1% | Apr 12, 2024 |
| Piper Sandler | Charles Neivert | $260 | $227.45 | -8.1% | Apr 3, 2024 |
| Barclays | Manav Patnaik | $260 | $222.09 | -8.1% | Feb 28, 2024 |
| RBC Capital | Ashish Sabadra | $213 | $188.61 | -24.8% | Jul 18, 2023 |
| Mizuho Securities | Christopher Parkinson | $177 | $173.36 | -37.5% | May 3, 2023 |
| Wells Fargo | Analyst unavailable | $168 | $152.72 | -40.7% | Jan 13, 2023 |
| Citigroup | Analyst unavailable | $164 | $150.44 | -42.1% | Dec 15, 2022 |
| Deutsche Bank | David Begleiter | $135 | $142.98 | -52.3% | Nov 2, 2022 |
| RBC Capital | Ashish Sabadra | $190 | $162.77 | -32.9% | Jul 26, 2022 |
| Credit Suisse | John Roberts | $195 | $148.17 | -31.1% | Jun 20, 2022 |
| UBS | Joshua Spector | $205 | $145.63 | -27.6% | Jun 17, 2022 |
| Mizuho Securities | Christopher Parkinson | $198 | $169.34 | -30.1% | Apr 29, 2022 |
| J.P. Morgan | Analyst unavailable | $190 | $168.47 | -32.9% | Apr 27, 2022 |
| Atlantic Equities | Colin Isaac | $210 | $182.95 | -25.8% | Apr 10, 2022 |
| Bank of America Securities | Steve Byrne | $196 | $177.59 | -30.8% | Mar 25, 2022 |
| Deutsche Bank | David Begleiter | $210 | $178.64 | -25.8% | Feb 20, 2022 |
| RBC Capital | Ashish Sabadra | $225 | $182.22 | -20.5% | Feb 16, 2022 |
| Credit Suisse | Kevin Mcveigh | $215 | $182.22 | -24.0% | Feb 16, 2022 |
| Robert W. Baird | Andrew Wittmann | $198 | $182.66 | -30.1% | Feb 15, 2022 |
| Mizuho Securities | Chris Parkinson | $210 | $182.66 | -25.8% | Feb 15, 2022 |
| Goldman Sachs | Robert Koort | $194 | $194.46 | -31.5% | Jan 21, 2022 |
| Evercore ISI | Stephen Richardson | $235 | $219.64 | -17.0% | Dec 3, 2021 |
| Vertical Research | Kevin McCarthy | $189 | $217.1 | -33.2% | Sep 27, 2021 |
Track every rating change on ECL the moment it posts. Free to start.
Start free